A foot-volume-measuring device using 3D imagery and AI to automatically monitor heart failure patients, reducing hospital stays by 165,000 bed-days/year

使用 3D 图像和 AI 的足部体积测量设备可自动监测心力衰竭患者，每年可减少 165,000 个床位日的住院时间

• 批准号: 10047020
• 金额: $ 44.1万
• 依托单位: HEARTFELT TECHNOLOGIES LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10047020
• 关键词: foot; volume; measuring; device; using

The catalyst behind Heartfelt was a conversation with a heart transplant surgeon in 2015 that prompted a simple question: 'Do you know that half the people I operate on wouldn't require surgery at all if they had reported their symptoms in time?'. Further research enabled the Heartfelt founders to unearth the hidden problem of "non-adherent' patients. These are mostly elderly people, often living alone, many with deteriorating mental capacity, who are unable to follow the advice given to them by their doctors. Instead of calling for help as their symptoms get worse, they end up as emergency hospital admissions. There are over 60 million people globally with heart failure - a terminal illness with worse survival statistics than most cancers. The cost of treating them is substantial, roughly £1.7billion/year in the UK alone, most of which is spent delivering expensive and often preventable hospital treatments. Heartfelt's vision is to address this problem with an autonomous monitoring device that sits in the patient's home, measuring changes in foot volume -- key indicator of heart problems -- and triggering alerts and thus timely medical intervention. It has the potential to improve the life quality of millions of heart patients, and also to save the NHS money and reduce waiting time in A&E by freeing up hospital beds. Heartfelt's monitor is fully automatic and requires no interaction with the patient. The foot volume data is uploaded to the cloud and analysed using artificial intelligence, which watches for critical changes. It is complicated, cutting-edge technology, protected by patent but utterly simple to use. Pilot trials on hundreds of UK-based patients have demonstrated the effectiveness of the monitors. The main aim of the project is to finalise the development of the next-generation device, readying it for manufacturing and regulatory approvals ahead of starting commercialisation.

Heartfelt 背后的催化剂是 2015 年与一位心脏移植外科医生的一次谈话，谈话中提出了一个简单的问题：“你知道吗，我接受手术的一半患者如果及时报告症状，根本不需要手术？”通过研究，Heartfelt 创始人发现了“不依从”患者的隐藏问题，这些患者大多是老年人，通常独居，许多人的心智能力不断恶化，无法听从医生的建议。呼吁全球有超过 6000 万人患有心力衰竭，这是一种生存统计数据比大多数癌症更糟糕的绝症，治疗这些患者的费用很高，大约为 17 亿英镑/人。仅在英国一年，大部分费用都用于提供昂贵且通常可以预防的医院治疗，Heartfelt 的愿​​景是通过安装在患者家中的自动监测设备来解决这个问题，测量足部体积的变化——心脏问题的关键指标。 ——并触发Heartfelt 的监测仪是全自动的，无需任何交互，从而可以提高数百万心脏病患者的生活质量，并通过释放医院床位来节省 NHS 资金并减少急症室的等待时间。足部体积数据被上传到云端并使用人工智能进行分析，该技术可监视关键变化。这是一种复杂的尖端技术，受专利保护，但使用起来却令人耳目一新。基础患者已证明该项目的主要目标是完成下一代设备的开发，为开始商业化之前的制造和监管审批做好准备。